Regenxbio Inc (RGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2006 | |
| Sales | 6,120 | 6,087 | 0 |
| Cost of Goods | 1,007 | 324 | N/A |
| Gross Profit | 5,113 | 5,763 | N/A |
| Operating Expenses | 8,802 | 10,863 | 0 |
| Operating Income | -3,682 | -4,776 | N/A |
| Interest Expense | 321 | 611 | 0 |
| Pre-tax Income | -4,003 | -5,387 | 0 |
| Net Income Continuous | -4,003 | -5,387 | N/A |
| Net Income | $-4,003 | $-5,387 | $N/A |
| EPS Basic Total Ops | -1.82 | -2.50 | N/A |
| EPS Basic Continuous Ops | -1.51 | -2.32 | N/A |
| EPS Diluted Total Ops | -1.82 | -2.50 | N/A |
| EPS Diluted Continuous Ops | -1.51 | -2.32 | N/A |
| EBITDA(a) | $-3,682 | $-4,776 | $N/A |